Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials
- 11 October 2007
- Vol. 335 (7626), 925
- https://doi.org/10.1136/bmj.39343.511389.be
Abstract
Objective To review the evidence base from randomised controlled trials of combined cardiac resynchronisation therapy and implantable cardioverter defibrillator therapy in left ventricular impairment and symptomatic heart failure.Design Bayesian network meta-analysis.Data sources Medline, Embase, and Cochrane databases up to June 2006.Review methods Two reviewers independently assessed trial eligibility and quality. Included trials compared cardiac resynchronisation therapy, implantable cardioverter defibrillator therapy, combined resynchronisation and implantable defibrillator therapy, and medical therapy alone, in patients with impaired left ventricular systolic function. Bayesian random effects network models were used to examine overall number of deaths.Results 12 studies including 1636 events in 8307 patients were identified. Combined cardiac resynchronisation and implantable cardioverter defibrillator therapy reduced the number of deaths by one third compared with medical therapy alone (odds ratio 0.57, 95% credible interval 0.40 to 0.80) but did not further improve survival when compared with implantable defibrillator therapy (0.82, 0.57 to 1.18) or resynchronisation (0.85, 0.60 to 1.22) therapy alone.Conclusion Evidence from randomised controlled trials is insufficient to show the superiority of combined cardiac resynchronisation and implantable cardioverter defibrillator therapy over cardiac resynchronisation therapy alone in patients with left ventricular impairment.Keywords
This publication has 42 references indexed in Scilit:
- Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial InfarctionNew England Journal of Medicine, 2004
- Evaluating non-randomised intervention studiesHealth Technology Assessment, 2003
- New pacing technologies for heart failureBMJ, 2003
- Effectiveness of implantable defibrillators for preventing arrhythmic events and deathJournal of the American College of Cardiology, 2003
- Implantable Cardioverter Defibrillators in Primary and Secondary PreventionAnnals of Internal Medicine, 2003
- Cardiac Resynchronization and Death From Progressive Heart FailureJAMA, 2003
- Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillationEuropean Heart Journal, 2002
- long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delayJournal of the American College of Cardiology, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Funnel plots for detecting bias in meta-analysisJournal of Clinical Epidemiology, 2001